Cross-Market Thesis
“Skin cancer vaccine approval delayed past 2027”
This trader is expressing a view that Skin cancer vaccine FDA approved by December 31, 2027? are correlated outcomes, committing $1,110 to this thesis across 1 prediction market on Polymarket.
S
Sharp_0x2779878% win rate
Total
$1,110
Markets
1